Droxidopa Trial
Phase 2
75
about 2.6 years
18–70
1 site in NY
What this study is about
This trial is testing whether droxidopa, a medication, can help improve blood flow to the kidneys in people with liver cirrhosis who develop kidney problems while in the hospital. The goal is to see if droxidopa helps raise blood pressure without intensive care or invasive treatments in 75 hospitalized patients with cirrhosis and kidney injury. Researchers will monitor changes in blood pressure and kidney function to determine if droxidopa is effective and safe for these patients.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Placebo
- 2.Take Droxidopa capsules
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
droxidopa
oral (Oral Capsule)
Secondary: All-cause mortality, Change in serum creatinine
Renal, Gastroenterology